论文部分内容阅读
目的:探讨三种血液净化治疗尿毒症透析后心包炎的对照研究结果。方法:选取我院就诊的尿毒症透析后心包炎患者共90例,将患者按照入院编号,随机分为三组:HFD、HD+HP和HD三组,将三组患者治疗前和治疗后的结果进行对比分析。结果:三组患者接受治疗前和治疗后胸痛、胸闷、气促、胸腔积液、脉压差、心包积液以及皮肤瘙痒状况中可以明显看出:HD+HP与HFD组相比P>0.05;HD+HP与HD组相比P>0.05;HFD与HD组相比P>0.05。结论:临床上在治疗尿毒症透析后心包炎时,可以采用HD+HP治疗方法,能有效改善患者治疗效果,提高预后质量,获得非常理想的治疗效果,值得在临床上大力推广。
Objective: To investigate the results of three controlled trials of three kinds of blood purifying treatment of pericarditis after uremia dialysis. Methods: A total of 90 patients with pericarditis after dialysis were included in this study. The patients were randomly divided into three groups according to admission number: HFD, HD + HP and HD. The three groups were treated before and after treatment The results of comparative analysis. Results: The three groups of patients before and after treatment of chest pain, chest tightness, shortness of breath, pleural effusion, pulse pressure, pericardial effusion and skin itching status can be clearly seen: HD + HP and HFD group P> 0.05 ; HD + HP compared with HD group P> 0.05; HFD compared with HD group P> 0.05. Conclusion: In the treatment of pericarditis after uremia dialysis, we can use HD + HP treatment method, which can effectively improve the treatment effect, improve the quality of prognosis, and obtain the ideal therapeutic effect, which is worth to be popularized clinically.